Dispensary Taxes: Federal, State, and the 280E Impact
Dispensaries operate inside one of the most unusual tax environments in American business — federally illegal but state-licensed, generating real revenue while being denied deductions that every other retailer takes for granted. This page covers the mechanics of federal tax code Section 280E, how state and local cannabis taxes layer on top, and what the resulting financial structure looks like for licensed operators. The stakes are significant: effective tax rates for cannabis businesses routinely reach 60–70% of gross profit, not net income.
- Definition and scope
- Core mechanics or structure
- Causal relationships or drivers
- Classification boundaries
- Tradeoffs and tensions
- Common misconceptions
- Checklist or steps (non-advisory)
- Reference table or matrix
Definition and scope
Section 280E of the Internal Revenue Code (26 U.S.C. § 280E) was enacted by Congress in 1982, originally to prevent drug traffickers from deducting business expenses on federal tax returns. The provision disallows deductions or credits for any expense incurred in "a trade or business which consists of trafficking in controlled substances." Because cannabis remains a Schedule I controlled substance under the Controlled Substances Act (21 U.S.C. § 812), state-licensed dispensaries fall squarely within 280E's scope.
The practical effect: a licensed dispensary cannot deduct rent, payroll, utilities, marketing costs, or most operating expenses that any other retail business deducts as a matter of routine. The only cost-side relief available is Cost of Goods Sold (COGS) — the direct cost of acquiring or producing the product sold. COGS is not a deduction in the tax-code sense; it is an offset against gross receipts that arrives at gross income, and it survives 280E because it predates the deduction framework entirely.
This page exists within a broader dispensary regulatory context that shapes every financial decision a cannabis operator makes, from licensing fees to banking access.
Core mechanics or structure
The arithmetic of 280E is not complicated, but the consequences are severe. Under standard tax accounting, a business computes: Revenue − COGS = Gross Profit, then subtracts operating expenses to arrive at taxable income. Under 280E, the sequence stops at gross profit. Operating expenses do not reduce taxable income.
A dispensary with $2,000,000 in revenue, $800,000 in COGS, and $700,000 in operating expenses (rent, staff, insurance, software) has:
- Gross profit: $1,200,000
- Taxable income under 280E: $1,200,000 (operating expenses disallowed)
- Taxable income under normal rules: $500,000
At a federal corporate rate of 21% (IRS Publication 542), the 280E-affected business pays approximately $252,000 in federal income tax versus roughly $105,000 under normal rules. That gap — $147,000 in this example — is the 280E penalty, and it scales directly with revenue.
COGS allocation becomes the central financial battleground. Dispensaries that cultivate or manufacture their own products (vertically integrated operations) can capture more costs inside COGS by applying inventory accounting rules under IRS Code § 263A (UNICAP). Pure retail dispensaries buying finished product from a licensed wholesaler have a narrower COGS base and feel 280E more acutely.
Causal relationships or drivers
280E's severity is a direct function of federal scheduling. Congress has not rescheduled cannabis, and until it does (or explicitly exempts state-licensed businesses from 280E), the provision applies mechanically regardless of state law. The Drug Enforcement Administration administers scheduling under the Controlled Substances Act, and any change to Schedule I status would cascade into 280E's applicability.
State and local tax structures add compounding pressure. The Tax Foundation tracks cannabis excise tax rates across legal states, and the variation is substantial:
- California imposes a 15% excise tax on retail cannabis sales, collected from distributors but embedded in product cost (California Department of Tax and Fee Administration).
- Washington applies a 37% cannabis excise tax at retail (Washington State Department of Revenue).
- Illinois uses a tiered excise based on THC potency, ranging from 10% to 25% (Illinois Department of Revenue).
These excise taxes are paid on top of standard sales tax — and in a 280E world, excise taxes that are not properly classified within COGS are themselves non-deductible operating costs.
Local municipalities add yet another layer. Cities and counties in California, Colorado, and Illinois have established local cannabis business taxes ranging from 1% to 15% of gross receipts. None of these are deductible at the federal level under 280E.
Classification boundaries
Not every cannabis business is affected by 280E identically. Classification of the business activity determines exposure:
Vertically integrated operators (cultivate → process → retail) can allocate a wider range of labor, overhead, and materials into COGS. The IRS examines these allocations closely; the Tax Court in Harborside v. Commissioner (T.C. Memo. 2012-84) established important precedent on which costs qualify.
Pure retail dispensaries that purchase finished goods have COGS limited largely to the wholesale purchase price plus direct acquisition costs (freight, required testing fees where they are direct product costs).
Hemp-derived CBD products — products derived from hemp with less than 0.3% THC — are not Schedule I substances following the 2018 Farm Bill (7 U.S.C. § 1639o), so a dispensary selling only compliant hemp products would not trigger 280E for that portion of sales. Mixed-inventory operators face allocation questions between lines.
Ancillary businesses — software vendors, landlords leasing to dispensaries, equipment suppliers — are not themselves trafficking controlled substances and are not subject to 280E. This distinction has driven the structure of many cannabis real estate and service arrangements.
Tradeoffs and tensions
The fundamental tension is that 280E treats a state-licensed, regulated, tax-paying business identically to an unlicensed drug trafficker. Both cannot deduct operating expenses. The legal cannabis operator, however, pays state licensing fees, submits to track-and-trace systems like METRC, undergoes laboratory testing requirements, and remits state excise taxes — none of which reduce federal taxable income.
This creates a peculiar competitive dynamic. A fully compliant licensed dispensary operating on thin margins can be less financially viable than an illicit operator carrying none of those structural costs. The Cannabis Regulators Association (CANNRA) has publicly cited 280E compliance costs as a direct contributor to the persistence of unregulated markets in high-tax states.
Operators pursuing COGS maximization through aggressive cost allocation risk IRS audit. The IRS has scrutinized cannabis tax returns at higher rates than general business returns, and disputes frequently reach Tax Court. Over-allocation into COGS — treating salary costs as direct production labor when they are actually administrative — is the most common audit trigger.
The rescheduling discussion adds planning uncertainty. If the DEA were to move cannabis to Schedule III, 280E would no longer apply by its own terms, because Schedule III substances are not covered. Operators making long-term financial commitments must model both scenarios.
Common misconceptions
"State legalization removes 280E." It does not. 280E is a federal provision and operates independently of state law. A dispensary in a fully legal state files a federal return subject to 280E exactly as one in a medical-only state does.
"Dispensaries pay no taxes." The opposite is closer to reality. Dispensaries pay federal income tax on grossly inflated taxable income, plus state income or franchise taxes, plus state excise taxes, plus local business taxes, plus standard payroll taxes. The IRS Chief Counsel Advice Memorandum 201504011 confirmed that state-licensed cannabis businesses are subject to federal income tax even while 280E disallows deductions.
"COGS can include any business expense with creative accounting." The IRS specifically reviews cannabis returns for improper COGS inflation. The Tax Court in Patients Mutual Assistance Collective Corporation v. Commissioner (T.C. Memo. 2020-11) rejected a dispensary's attempt to classify marketing and administrative costs as COGS.
"Banking problems are the main financial issue." The dispensary banking and payments landscape is genuinely difficult, but for many operators the tax burden — not banking access — is the primary factor constraining capital formation and expansion.
Checklist or steps (non-advisory)
The following represents the structural sequence of tax-related determinations a cannabis business typically works through with qualified tax professionals:
- Determine federal classification exposure — confirm whether all product lines involve Schedule I substances or include exempt hemp-derived products under the 2018 Farm Bill.
- Identify business structure — distinguish vertically integrated operations from pure retail to assess the realistic COGS base available.
- Map allowable COGS components — direct product purchase costs, inbound freight, direct cultivation labor (if applicable), direct materials, and state-mandated testing fees directly tied to product.
- Apply UNICAP rules (§ 263A) — vertically integrated operators allocate indirect production costs into inventory using IRS-prescribed methods; documentation of method is required.
- Calculate state excise tax treatment — determine whether state excise taxes are embedded in product cost (and thus potentially in COGS) or are separately stated selling costs.
- Compile local and municipal cannabis business tax obligations — these vary by jurisdiction and municipality; California's city-level taxes alone span more than 50 distinct rate schedules.
- Reconcile federal and state taxable income — states that have decoupled from federal 280E treatment (California, Colorado, and others have done so partially) require a separate state return calculation.
- Retain supporting documentation — COGS allocations, inventory records, production logs, and cost-accounting methodologies must be preserved for IRS audit defense.
Reference table or matrix
| Tax Layer | Who Imposes It | Rate Range | 280E Impact |
|---|---|---|---|
| Federal income tax (280E-affected) | IRS / U.S. Congress | 21% corporate; 10–37% individual | COGS offset only; no operating expense deduction |
| State excise tax (cannabis-specific) | State legislature | 10% (AZ) – 37% (WA) | Non-deductible federally; varies by state treatment |
| State sales tax | State revenue dept. | 0% (MT medical) – 10.25% (CA) | Non-deductible federally |
| Local cannabis business tax | City / county | 1% – 15% gross receipts | Non-deductible federally |
| Payroll taxes (employer share) | IRS / SSA | 7.65% of wages (FICA) | Non-deductible federally under 280E |
| State income / franchise tax | State revenue dept. | Varies; CA has 280E decoupling | May allow operating expense deductions |
States that have enacted partial or full decoupling from federal 280E treatment — allowing operating expense deductions on state returns — include California (AB 37, 2020) and Colorado. The decoupling provides meaningful state-level relief but does not reduce the federal burden.
The full landscape of how cannabis businesses are regulated from state licensing through federal compliance is mapped in the dispensary authority index, which situates the tax framework within the broader operational structure of licensed cannabis retail.